Figure 6.
Plasma in combination with vaccination enhanced cancer-specific T-cell responses. A) Mice were challenged with CT26-GUCY2C cells (Day 0) and treated with plasma on day 7. A subgroup of the plasma-treated mice was vaccinated on day 14 with Ad5-GUCY2C-S1. B) GUCY2C-specific and C) AH1-specific T-cell responses were quantified by IFNγ ELISpot in the spleen o.